Literature DB >> 6185815

The transsynaptic regulation of the septal-hippocampal cholinergic neurons.

E Costa, P Panula, H K Thompson, D L Cheney.   

Abstract

There is not yet a complete understanding of the functional interactions among various septal nuclei which regulate hippocampal function. Nevertheless, much has been learned histologically and biochemically about the major connections of the distinct areas of the septal complex and the chemical character of some of these pathways. The cholinergic septal-hippocampal pathway serves as a well defined link between these two important structures of the limbic system. Acetylcholine turnover rates in the hippocampus have been shown to increase or decrease proportionally to the activity of the cholinergic neurons originating in the septum. Moreover, these turnover rates have been shown to be modulated by intraseptal injections of agonists or antagonists of various neurotransmitters or neuromodulators which are stored in various cell groups located in the septum. By coupling this biochemical approach with techniques to study the receptor organization, greater detail concerning the transmitter and cotransmitter interactions among the various neuromodulators can be obtained.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6185815     DOI: 10.1016/0024-3205(83)90028-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  Opioids suppress IPSCs in neurons of the rat medial septum/diagonal band of Broca: involvement of mu-opioid receptors and septohippocampal GABAergic neurons.

Authors:  M Alreja; M Shanabrough; W Liu; C Leranth
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

2.  Brain reinforcement system function is ghrelin dependent: studies in the rat using pharmacological fMRI and intracranial self-stimulation.

Authors:  Paul J Wellman; P Shane Clifford; Juan A Rodriguez; Samuel Hughes; Carla Di Francesco; Sergio Melotto; Michela Tessari; Mauro Corsi; Angelo Bifone; Alessandro Gozzi
Journal:  Addict Biol       Date:  2011-10-21       Impact factor: 4.280

3.  Electrophysiological actions of GABAB agonists and antagonists in rat dorso-lateral septal neurones in vitro.

Authors:  C Bon; M Galvan
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

4.  Increasing acetylcholine levels in the hippocampus or entorhinal cortex reverses the impairing effects of septal GABA receptor activation on spontaneous alternation.

Authors:  A Degroot; M B Parent
Journal:  Learn Mem       Date:  2000 Sep-Oct       Impact factor: 2.460

5.  Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area.

Authors:  B S Givens; G R Breese
Journal:  J Pharmacol Exp Ther       Date:  1990-08       Impact factor: 4.030

6.  Differential modulation of dopaminergic systems in the rat brain by dietary protein.

Authors:  S M Farooqui; J W Brock; E S Onaivi; A Hamdi; C Prasad
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

7.  Dopamine and serotonin metabolism in striatum and in the septohippocampal pathway of the Snell dwarf mouse.

Authors:  E Kempf; G Fuhrmann; G Thiriet; A Ebel
Journal:  Neurochem Res       Date:  1985-07       Impact factor: 3.996

8.  A comparison of the effects of scopolamine and diazepam on acquisition and retention of inhibitory avoidance in mice.

Authors:  M W Decker; T Tran; J L McGaugh
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 9.  Septohippocampal acetylcholine: involved in but not necessary for learning and memory?

Authors:  Marise B Parent; Mark G Baxter
Journal:  Learn Mem       Date:  2004 Jan-Feb       Impact factor: 2.460

10.  Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat.

Authors:  F Camacho; C P Smith; H M Vargas; J T Winslow
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.